期刊文献+

VEGF—C反义多肽对人肝癌细胞HepG2增殖及侵袭的抑制效应

Anti-tumor effect of antisense peptide of VEGF-C on human hepatic cancer cells HepG2
原文传递
导出
摘要 目的检测血管内皮生长因子-C(VEGF—C)反义多肽对人肝癌细胞增殖和侵袭能力的影响。方法制备VEGF-C的反义多肽,通过与肝癌细胞株HepG2共培养,用四甲基偶氮唑盐微量酶反应比色法(MTY)检测细胞增殖率,人工基底膜侵袭实验检测细胞侵袭能力;构建肝癌细胞HepG2裸鼠皮下移植瘤模型,瘤体内注射YEGF—C反义多肽,观察其对肝癌细胞的抑制作用;WesternBlot检测VEGF-C在瘤组织的表达情况;免疫组化分析肿瘤组织VEGFR-3阳性脉管密度。结果VEGF—C反义多肽具有较强的生物学活性,对肝癌细胞具有明显增殖抑制作用(P〈0.05);25、50、100μg/mlVEGF-C反义多肽对侵袭重组基底膜的抑制率分别为41.7%、57.3%和66.9%(P〈0.05);瘤组织内给予VEGF-C反义多肽后,肿瘤生长受抑制(P〈0.05),WesternBlot分析VEGF—C在瘤组织中的表达降低(P〈0.05);免疫组化分析VEGF-C反义多肽可抑制肿瘤组织YEGFR-3阳性脉管形成(P〈0.05)。结论制备出的VEGF-C反义多肽具有良好的生物学活性,通过抑制肝癌细胞的增殖、侵袭能力及肿瘤组织VEGFR-3阳性脉管形成而发挥抗肝癌作用。 Objective To investigate the anti-tumor effects of the antisense peptide of vascular endothelial growth factor(VEGF)-C on proliferation and invasion ability of human hepatic cancer cell. Methods Antisense peptide of VEGF-C was prepared, hepatic cancer cell line HepG2 was treated by antisense peptide of VEGF-C, the cell-growth rate was evaluated by MTT method and the invasive capacity was evaluated by reconstituted basement membrane invasion assay. The model of subcutaneous tumor was generated by injection of HepG2 cells into the nude mice, antisense peptide of VEGF- C was subcutaneously injected around xenograft tumors after tumor cell innoculation. Tumor growth was observed, VEGF-C expression was measured by western blot and formation of VEGFR-3 positive vessels in tttmor tissues was analyzed by immunohistochemical analysis. Results VEGFC antisense peptide effectively inhibited HepG2 cells growth( P 〈0. 05), suppression ratio of HepG2 cells invasion was 41.7% ,57. 3% and 66. 9% according to VEGF-C antisense peptide concentration of 25,50 and 100 μg/ml ( P 〈0. 05). Tumor growth was significantly inhibited in mice injected with antisense peptide of VEGF-C ( P 〈0. 05). Western blot analysis showed expression of VEGF-C protein was also inhibited( P 〈0. 05) ; nalysis demonstrated significant reduction of VEGFR-3 positive vessel formation in tumor tissues( P 〈0. 05). Conclusion Antisense peptide of VEGF-C shows effective biological activity, and it can inhibit tumor growth through inhibiting tumor cell proliferation, suppressing tumor invasion and inhibiting VEGFR-3 positive vessel formation.
出处 《国际肿瘤学杂志》 CAS 2008年第1期72-75,共4页 Journal of International Oncology
关键词 肝肿瘤 HEPG2细胞 寡核苷酸类 反义 血管内皮生长因子类 Liver neoplasmas HepG2 cell Oligonucleotides, antisense Vascular endothelial growth factors
  • 相关文献

参考文献10

  • 1Takeda A, Stoeltzing O, Ahmad SA, et al. Role of angiogenesis in the development and growth of liver metastasis. Ann Surg Oncol,2002,9 (7) :610-616.
  • 2李书华,张雅洁,王燕菲,李杰荣.VEGFR-3反义多肽的原核表达及其意义[J].广州医学院学报,2004,32(2):10-13. 被引量:3
  • 3Su JL, Yang PC, Shih JY, et al. The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells. Cancer Cell, 2006,9(3):209-223.
  • 4Furudoi A, Tanaka S, Haruma K, et al. Clinical significance of vascular endothelial growth factor C expression and angiogenesis at the deepest invasive site of advanced colorectal carcinoma. Oncology, 2002,62(2):157-166.
  • 5Pradeep CR, Sunila ES, Kuttan G. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies. Integr Cancer Ther,2005,4(4):315-321.
  • 6Roy H, Bhardwaj S, Yla- Herttuala S. Biology of vascular endothelial growth factors. FEBS Lett,2006, 580(12):2879-2887.
  • 7Li YS, Kaneko M, Amatya VJ, et al. Expression of vascular endothelial growth factor- C and its receptor in invasive micropapillary carcinoma of the breast. Pathol Int,2006,56(5):256-261.
  • 8Onogawa S, Kitadai Y, Amioka T, et al. Expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in early gastric carcinoma: correlation with clinicopathological parameters. Cancer Lett, 2005,226(1) :85-90.
  • 9Miyahara M, Tanuma J, Sugihara K, et al. Tumor lymphansiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma. Cancer, 2007,110(6 ):1287-1294.
  • 10Yamaguchi R, Yano H, Nakashima O, et al. Expression of vascular endothelial growth faetor-C in human hepatocellular carcinoma. J Gastroenterol Hepatol,2006,21(1):152-160.

二级参考文献9

  • 1陆凤先,王伟,汤特.应用催产素反义肽识别催产素体复合物[J].中国病理生理杂志,1996,12(3):239-243. 被引量:3
  • 2DeMartino JA, Van Riper G, Siciliano SJ,et al. The amino terminus of the human C5a receptor is required for high affinity C5a binding and for receptor activation by C5a but not C5a analogs[J]. J Biol Chem, 1994,269(20) :14446-50.
  • 3Stachowiak K, Rodziewicz-Motowidlo S, Sosnowska R, etal.Effect of antisense peptide binding on the dimerization of human cystatin C - gel electrophoresis and molecular modeling studies[J]. Acta Biochim Pol, 2004,51 ( 1 ): 153- 60.
  • 4Shibuya M, Yamaguch S, Yamane A, et al. Nucleotide sequence and expression of a novall human receptor type tyrosine kinase gene (flt) closey related to the fms family[J]. Oncogene,1990;5(4) :519 -524.
  • 5Blalock JE, Bost KL. Binding of peptides that are specified by complementary RNAs[ J]. Bio chem, 1986,234:679.
  • 6Shai Y, Brunck TK, Chaiken IM. Antisense peptide recognition of sense peptides: sequence simplification and evaluation of forces underlying the interaction [ J ].Biochemistry. 1989, 28 (22): 8804 - 8811.
  • 7Baranyi L, Campbell W, Ohshima K, et al. The antisense homology box: a new motif within proteins that encodes biologically active peptides [ J ]. Nat Med, 1995,1 ( 9 ): 894- 901.
  • 8Fujita E, Farkas I, Campbell W, etal. Inactivation of C5a anaphylatoxin by a peptide that is complementary to a region of C5a[J]. J Immunol, 2004,172(10) :6382 -7.
  • 9J.萨姆布鲁克 弗里奇EF 曼尼阿蒂斯T.分子克隆实验指南(第二版)[M].北京:科学出版社,1995.1-1039.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部